Browse our anti-BRCA2 (BRCA2) Antibodies

Full name:: anti-Breast Cancer 2, Early Onset Antibodies (BRCA2)

On www.antibodies-online.com are 102 Breast Cancer 2, Early Onset (BRCA2) Antibodies from 0 different suppliers available. A total of 142 BRCA2 products are currently listed.

Synonyms:: 30169, AI256696, AW045498, BcDNA:SD25109, BRCA2, brcc2, brovca2, CG13583, CG13584, CG30169, dmbrca2, Dmel\\CG30169, facd, fad, fad1, fancb, FANCD, Fancd1, GLM3, PNCA2, RAB163

list all antibodies	Gene Name	GeneID	UniProt
Anti-Human BRCA2	BRCA2	675	P51587
Anti-Rat BRCA2	BRCA2	360254
Anti-Mouse BRCA2	BRCA2	12190	P97929
Show all synonyms

Relevant Pathways for anti-BRCA2 Antibodies

Maintenance of Protein Location

More product categories related to BRCA2 Antibody

Top referenced anti-BRCA2 Antibodies

Human Monoclonal BRCA2 Primary Antibody for IHC, IHC (fro) - ABIN445493 : Bernard-Gallon, Déchelotte, Vissac, Aunoble, Cravello, Malpuech, Bignon: BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite. in Breast cancer research : BCR 2001 (PubMed)
Show all 2 Pubmed References
Human Monoclonal BRCA2 Primary Antibody for IHC, IHC (p) - ABIN445491 : Wu, Jiang, Thangaraju, Wu, Couch: Induction of the BRCA2 promoter by nuclear factor-kappa B. in The Journal of biological chemistry 2000 (PubMed)
Show all 2 Pubmed References
Human Polyclonal BRCA2 Primary Antibody for IHC, IHC (fro) - ABIN4285196 : Moeller, Yordy, Williams, Giri, Raju, Molkentine, Byers, Heymach, Story, Lee, Sturgis, Weber, Garden, Ang, Schwartz: DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy. in Clinical cancer research : an official journal of the American Association for Cancer Research 2011 (PubMed)
Human Polyclonal BRCA2 Primary Antibody for ICC, IF - ABIN4285198 : Sergeeva, Ershova, Veiko, Malinovskaya, Kalyanov, Kameneva, Stukalov, Dolgikh, Konkova, Ermakov, Veiko, Izhevskaya, Kutsev, Kostyuk: Low-Dose Ionizing Radiation Affects Mesenchymal Stem Cells via Extracellular Oxidized Cell-Free DNA: A Possible Mediator of Bystander Effect and Adaptive Response. in Oxidative medicine and cellular longevity 1970 (PubMed)

More Antibodies against BRCA2 Interaction Partners

Human Breast Cancer 2, Early Onset (BRCA2) interaction partners

In our EOBC cohort, a contralateral breast cancer was diagnosed in ~60% of BRCA1/2 carriers, but only in 8% of non-carriers. These findings show that BRCA1/2 mutations overwhelmingly lead to a contralateral disease when breast cancer is diagnosed at early age.
Results showed that BRCA2 is down-regulated in epithelial ovarian cancer by lncRNA RP11 (show PRPF31 Antibodies)-552M11.4 which promotes cell proliferation, migration and invasion.
We describe twenty-nine novel BRCA1 and BRCA2 variants detected in Italian individuals suffering from hereditary breast and ovarian cancer syndrome (HBOC).
BRCA2 and CHEK2 play an important role in the genetic susceptibility to urinary tract cancers.
The work-flow represents a robust and easy-to-use method for full BRCA1/2 screening, which can be easily implemented in routine diagnostic testing and adapted to genes other than BRCA1/2.
Statistically significant correlations were identified between breast cancer and 3 not described previously single nucleotide polymorphisms of homologous recombination repair genes BRCA1 and BRCA2: rs59004709, rs4986852 and rs1799950.
The present study shows that the G allele carriers of BRCA2 rs9534275 were associated with increased serum total cholesterol and ApoB (show APOB Antibodies) levels in the coronary artery disease patients and increased risk of coronary artery disease and ischemic stroke.
BRCA2 rs144848 polymorphism is associated with cancer.
Inactivation of homologous recombination factors BRCA1, BRCA2, or RAD51 (show RAD51 Antibodies) hypersensitizes cells to acetaldehyde treatment, in spite of the Fanconi anemia (show PALB2 Antibodies) pathway being functional.
Tumours arising in BRCA2 mutation carriers showed significantly higher methylation of candidate genes, than those arising in non-BRCA2 familial MBCs (average AMI (show CFD Antibodies) 23.6 vs 16.6, p = 0.01, 45% of genes hypermethylated vs 34%, p < 0.01).

Fruit Fly (Drosophila melanogaster) Breast Cancer 2, Early Onset (BRCA2) interaction partners

persistent meiotic DNA double-strand breaks might correspond to crossovers, which are mobilized to the nuclear envelope for their repair; Brca2-Pds5 complexes may be key mediators of this process.
A mutation in Cyp6d2, a cytochrome P450 (show PHM Antibodies) gene, when combined with a brca2 mutation, resulted in synergistic hypersensitivity to camptothecin.
DNA repair by homologous recombination is dramatically decreased in CG30169 (brca2 homolog) mutants.

Zebrafish Breast Cancer 2, Early Onset (BRCA2) interaction partners

the data suggest for the first time that brca2/fancd1 is essential for vertebrate kidney ontogeny.
Carcinogenesis in zebrafish with combined mutations in tp53 (show TP53 Antibodies) and brca2 typically requires biallelic mutation or loss of at least one of these genes.
The novel role of Brca2 in organizing the vertebrate egg nucleus may provide new insights into the origin of ovarian cancer
critical roles for brca2 in ovarian development and tumorigenesis in reproductive tissues

Mouse (Murine) Breast Cancer 2, Early Onset (BRCA2) interaction partners

Data indicate the importance of breast cancer 1 (show BRCA1 Antibodies) protein (BRCA1 (show BRCA1 Antibodies))/breast cancer 2 protein (BRCA2) function in cranial neural crest cells (CNCCs) during craniofacial skeletal formation.
we generated a Brca2 knock-in mouse model lacking exons 4-7 and demonstrated that these exons are dispensable for viability as well as tumor-free survival. This study provides the first in vivo evidence of the functional significance of a minor transcript of BRCA2 that can play a major role in the survival of humans who are homozygous for a clearly pathogenic mutation.
we describe a genetic approach to examine the functional significance of the interaction between BRCA2 and PALB2 (show PALB2 Antibodies) by generating a knock-in mouse model of Brca2 carrying a single amino acid change (Gly25Arg, Brca2G25R) that disrupts this interaction. In addition, we have combined Brca2G25R homozygosity as well as hemizygosity with Palb2 (show PALB2 Antibodies) and Trp53 (show TP53 Antibodies) heterozygosity .
Merit40 (show BABAM1 Antibodies) mutation exacerbated ICL-induced chromosome instability in the context of concomitant Brca2 deficiency but not in conjunction with Fancd2 (show FANCD2 Antibodies) mutation.
Heterozygous and homozygous Brca2 mutation may lead to dysfunction in T cell populations.
BRCA2 exon 27 domain maintains chromosomal integrity at both stalled and collapsed replication forks consistent with involvement in both replication fork maintenance and double strand break repair.
we use a genetically engineered mouse model of BRCA2-associated hereditary breast cancer to study drug resistance to several types of chemotherapy and PARP (show PARP1 Antibodies) inhibition.
BRCA2-mediated sequestration of nuclear RAD51 (show RAD51 Antibodies) serves to prevent inappropriate DNA interactions.
BRCA2 directly represses the expression of IFN-related genes
the models reveal novel aspects of cancer evolution in carriers of germline BRCA2 mutations, provide new insights into the tumour suppressive role of BRCA2

BRCA2 Antigen Profile

Antigen Summary

Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele.

Alternative names and synonyms associated with BRCA2

BRCA2, DNA repair associated (BRCA2) antibody
Breast cancer 2, early onset homolog (Brca2) antibody
BRCA2, DNA repair associated (Brca2) antibody
breast cancer 2, early onset (brca2) antibody
breast cancer 2, early onset (LOC584780) antibody
BRCA2, DNA repair associated (brca2) antibody
breast cancer 2, early onset (Brca2) antibody

30169 antibody
AI256696 antibody
AW045498 antibody
BcDNA:SD25109 antibody
BRCA2 antibody
brcc2 antibody
brovca2 antibody
CG13583 antibody
CG13584 antibody
CG30169 antibody
dmbrca2 antibody
Dmel\\CG30169 antibody
facd antibody
fad antibody
fad1 antibody
fancb antibody
FANCD antibody
Fancd1 antibody
GLM3 antibody
PNCA2 antibody
RAB163 antibody

Protein level used designations for BRCA2

BRCA1/BRCA2-containing complex, subunit 2 , breast and ovarian cancer susceptibility gene, early onset , breast cancer 2 tumor suppressor , breast cancer type 2 susceptibility protein , fanconi anemia group D1 protein , truncated breast and ovarian cancer susceptibility protein 2 , breast cancer 2, early onset homolog , CG30169-PA , Brca2-PA , breast cancer 2, mutation 1, University of Wisconsin-Madison , breast cancer susceptibility protein 2 , breast cancer type 2 susceptibility protein homolog , fanconi anemia group D1 protein homolog , breast and ovarian cancer susceptibility protein 2 , breast cancer 2, early onset , breast cancer type 2 susceptibility protein-like

GENE ID	SPECIES
675	Homo sapiens
37916	Drosophila melanogaster
360254	Rattus norvegicus
374139	Gallus gallus
493878	Felis catus
566758	Danio rerio
584780	Strongylocentrotus purpuratus
721981	Macaca mulatta
100397509	Callithrix jacchus
452526	Pan troglodytes
474180	Canis lupus familiaris
100038818	Xenopus (Silurana) tropicalis
100601625	Nomascus leucogenys
12190	Mus musculus
100064578	Equus caballus
507069	Bos taurus

Did you look for something else?

Phone:	+1 877 302 8632
Fax:	+1 888 205 9894 (Toll-free)
E-Mail:	orders@antibodies-online.com

Show all anti-Breast Cancer 2, Early Onset (BRCA2) Antibodies with Pubmed References